The Impact of Anemia on Long-Term Clinical Outcome in Patients Undergoing Revascularization With the Unrestricted Use of Drug-Eluting Stents | Zendy

Thomas Pilgrim | Zendy; Florian Vetterli | Zendy; Bindu Kalesan | Zendy; Giulio Stefanini | Zendy; Lorenz Räber | Zendy; Stefan Stortecky | Zendy; Steffen Gloekler | Zendy; Ronald K. Binder | Zendy; Peter Wenaweser | Zendy; Aris Moschovitis | Zendy; Ahmed A. Khattab | Zendy; Lutz Buellesfeld | Zendy; Marcel Zwahlen | Zendy; Bernhard Meier | Zendy; Peter Jüni | Zendy; Stephan Windecker | Zendy

Open Access

The Impact of Anemia on Long-Term Clinical Outcome in Patients Undergoing Revascularization With the Unrestricted Use of Drug-Eluting Stents

Author(s) -

Thomas Pilgrim,

Florian Vetterli,

Bindu Kalesan,

Giulio Stefanini,

Lorenz Räber,

Stefan Stortecky,

Steffen Gloekler,

Ronald K. Binder,

Peter Wenaweser,

Aris Moschovitis,

Ahmed A. Khattab,

Lutz Buellesfeld,

Marcel Zwahlen,

Bernhard Meier,

Peter Jüni,

Stephan Windecker

Publication year - 2012

Publication title -

circulation cardiovascular interventions

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.621

H-Index - 95

eISSN - 1941-7632

pISSN - 1941-7640

DOI - 10.1161/circinterventions.111.965749

Subject(s) - medicine , anemia , hazard ratio , confidence interval , percutaneous coronary intervention , conventional pci , myocardial infarction , kidney disease , hemoglobin , surgery

Anemia is frequent among patients with cardiovascular disease and adversely affects prognosis. The objective of this analysis was to assess the impact of anemia on long-term clinical outcomes among patients undergoing percutaneous coronary intervention (PCI) with the unrestricted use of drug-eluting stents (DES).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research